CardieX Limited (CDEX)

CardieX was planning to go public, but the IPO was withdrawn on Sep 26, 2023.
IPO Price Range
$7.50 - $8.00
Shares Offered
Deal Size
Chart not available yet
Data will show when the stock starts trading.
Market Cap 27.98M
Revenue (ttm) 3.21M
Net Income (ttm) -9.71M
Shares Out 3.61M
EPS (ttm) -2.69
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About CDEX

CardieX is a commercial-stage digital healthcare company using our medical devices to redefine the way hypertension, cardiovascular disease (CVD), and other major vascular diseases are clinically diagnosed and managed. Our SphygmoCor XCEL is a vital signs and vascular biometric monitoring device that offers non-invasive assessment of the central aortic pressure waveform, including both pressures and indices of arterial stiffness, providing noninvasive measurement of arterial pressure that the heart, brain, and kidneys actually experience. Our t... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1994
Employees 43
Stock Exchange NASDAQ
Ticker Symbol CDEX
Full Company Profile

Financial Performance

Financial Statements


CardieX IPO Registration Document (F-1)

CardieX has filed to go public with an IPO on the NASDAQ.

1 year ago - SEC